Guardant Health logo

Guardant Health Funding & Investors

Guardant Health, Inc. operates as a biotechnology company. The Company provides sequencing and cell diagnostics services for the cancer patients. Guardant Health serves patients worldwide.

https://guardanthealth.com/

Total Amount Raised: $1,890,700,032

Guardant Health Funding Rounds

  • Post Ipo Equity

    $90,700,000

    Post Ipo Equity Investors

    Baillie Gifford
  • Post Ipo Equity

    $250,000,000

  • Post Ipo Debt

    $1,000,000,000

  • IPO

    Unknown

  • Series E

    $360,000,000

    Series E Investors

    SoftBank Vision Fund
    Sequoia Capital
    Khosla Ventures
    Lightspeed Venture Partners
    OrbiMed Advisors
    8VC
    Temasek Holdings
    T. Rowe Price
    C.M. Capital Advisors
  • Series D

    $100,000,000

    Series D Investors

    OrbiMed Advisors
    Khosla Ventures
    Sequoia Capital
    Lightspeed Venture Partners
    Pear VC
    Formation 8
    Heritage Group
    Hone Capital
    Felicis
    Laszlo Bock
  • Series C

    $50,000,000

    Series C Investors

    Lightspeed Venture Partners
    Formation 8
    Khosla Ventures
    Sequoia Capital
    SGH Capital
    Felicis
    Ling Wong
  • Series B

    $30,000,000

    Series B Investors

    Khosla Ventures
    Sequoia Capital
    Signatures Capital
    Pear VC
    Ling Wong
  • Series A

    $10,000,000

    Series A Investors

    Sequoia Capital
    Farzad Nazem
    Osage University Partners II
    Frank Malek
    Cota Capital
Funding info provided by Diffbot.